Zoetis | ZTS - Operating Profit


Zoetis reported $1.03B in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
AbbVie USD 6.88B 156M Sep/2026
Align Technology USD 193.04M 1.72M Sep/2026
Bayer EUR 129M 698M Sep/2026
Bristol-Myers Squibb USD 255M 44M Sep/2026
Charles River Laboratories USD 202.64M 82.75M Sep/2026
Coherus Biosciences USD -39.08M 3.65M Dec/2025
Dentsply International USD 38M 46M Sep/2026
Eli Lilly USD 12.46B 2.68B Jun/2026
Henry Schein USD 193M 7M Sep/2026
Idexx Laboratories USD 402.35M 23.22M Sep/2026
Illumina USD 305M 45M Sep/2026
IQVIA Holdings USD 608M 1.99B Sep/2026
J&J USD 6.47B 1B Sep/2026
Laboratory Of America USD 418M 38.7M Sep/2026
Merck USD 7.33B 6.49B Sep/2026
Neogen USD -1.8M 4.9M Jun/2026
Pacira USD 2.57B 2.56B Sep/2026
Perrigo USD 27.2M 3.7M Sep/2026
Pfizer USD 662M 5M Sep/2026
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Quest Diagnostics USD 479M 20M Sep/2026
Sanofi EUR 4.72B 2.34B Sep/2026
Sanofi EUR 2.38B 115M Jun/2026
Zoetis USD 1.03B 88M Sep/2026